Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Insulin and sulfonylureas: GLP-1 and amylin both reduce postprandial glucagon and slow gastric emptying adding either to insulin or sulfonylureas increases hypoglycemia risk
The mechanism is well characterized
AOD9604 and Oral Bioavailability Research Pharmacokinetic profiling in pigs confirmed that AOD9604 is orally bioavailable, with intact peptide and its principal N-terminal truncation degradants (2aa and 3aa fragments) detected in plasma following oral dosing
As a 2025 narrative review in PubMed confirming BPC-157 promotes angiogenesis, accelerates tendon and bone healing, and protects gastrointestinal lining across multiple animal models notes, the current evidence base is robust in preclinical settings with no approved human trials completed to date
Erratic timing dosing at 9am one week and 6pm the next prevents this adaptation and can increase dropout risk
BPC-157 (Body Protection Compound-157) is a regenerative peptide originally derived from a protective protein in the stomach
US$ 25.58
US$ 29.04
US$ 23.77
US$ 26.20
US$ 21.16
US$ 28.30
US$ 27.29
US$ 27.29
US$ 25.65
US$ 22.06
US$ 25.58
US$ 22.87
US$ 26.73
US$ 21.06
